Cost of humira in ireland?

Question

Accepted Answer

Humira (adalimumab) – Cost Overview in Ireland (2024)

Item	Typical Cost	Notes
Single 40 mg vial	≈ €700 – €850	This is the standard dose for most indications (e.g., rheumatoid arthritis, Crohn’s disease, psoriasis). The price is set by the HSE’s Drug Price List and can vary slightly by pharmacy.
Monthly treatment	≈ €1,400 – €1,700	Humira is usually given every other week, so most patients receive two 40 mg vials per month.
Private insurance co‑pay	≈ €0 – €200	Many private plans cover 80 – 100 % of the drug cost. The out‑of‑pocket amount depends on the specific policy.
National Health Service (HSE)	Covered if clinically indicated	For eligible patients (e.g., rheumatoid arthritis, Crohn’s disease, ulcerative colitis, severe plaque psoriasis), the HSE will fund the drug through the Primary Care Pharmaceutical Services (PCPS) or the Chronic Disease Management programme. No direct cost to the patient in these cases.
Biosimilars	≈ €350 – €500 per vial	Biosimilar versions (e.g., Amjevita, Ctrach, Orencia‑C) are now available in Ireland and can be significantly cheaper. Some patients are switched to a biosimilar once it becomes available.

HSE Pricing – The HSE negotiates prices with the manufacturer and publishes a Drug Price List that pharmacies use.
National Formulary – Humira is on the National Formulary, and the price is set by a public‑private partnership.
Biosimilar Competition – Once a biosimilar enters the market, the price of Humira can be discounted, and patients may be switched to a cheaper alternative.
Insurance & Subsidy – Private insurers may cover a large portion of the cost; if not covered, patients can request a subsidy from the HSE through the Health Insurance Authority (HIA) for specific conditions.

Check Eligibility: If you have a condition that the HSE covers (e.g., rheumatoid arthritis, Crohn’s disease), contact your GP or specialist to confirm your eligibility for subsidised treatment.
Ask About Biosimilars: Discuss with your prescriber whether a biosimilar is an option for you; it may reduce your out‑of‑pocket cost.
Insurance: Review your private health plan’s formulary. Many plans list Humira and its biosimilars with detailed co‑pay information.
Pharmacy: Ask your pharmacy about current promotions or bulk‑purchase discounts—some pharmacies offer a small discount when you buy both vials together.

Bottom line:

Typical out‑of‑pocket cost (private): €1,400 – €1,700 per month for two vials.
If covered by HSE: No direct cost to the patient (subject to eligibility).
Biosimilars can cut the monthly cost by up to 50 %–60 % once they are approved and available.

If you need the exact price for a specific pharmacy or want to know whether a biosimilar is available to you, feel free to ask!

Ask Questions, Get Industry Insights … Instantly